Genmab — Marts 2017
-
MS-patienter har 17% større risiko for at udvikle chronic lymphocytic leukaemia (CLL). Så Ofatumumab kan måske være dobbelt gevinst for MS-patienter. Ofatumumab er godkendt til CLL og i fase 3 mod MS. http://www.ms-uk.org/people-ms-have-17-higher-risk-developing-leukaemia-080217
-
godt set Anette
-
Millionærklubben fra ca 20:44 lidt om Genmab. Nu drager oraklet Lau Svendsen en sammenligning med en aktie i Tivoli! http://www.radio24syv.dk/programmer/millionaerklubben/15835611/sporgsmal-fra-lytterne/
-
Det er fint at de mopper hinanden.
-
- A/B reducerede nettosalget med små 6000 stk.
-
https://pbs.twimg.com/media/C56DUeSUwAEoQDk?format=jpg&name=large Prøver denne, der viser at dara
giver 3 gange så mange mdr negative resondrre -
https://pbs.twimg.com/media/C56EdkEUwAAoH-n?format=jpg&name=large Ingen tilbagefald i high risk mrd negative respondre. Imponerende.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind